Po-Shun Lee

No open positions remaining

56 year

Health Technology

Consumer Services

Profile

Po-Shun Lee is the founder of Critical Biologics Corp.
which was founded in 2006.
He worked as an Associate Medical Director at Vertex Pharmaceuticals, Inc. from 2010 to 2013.
From 2014 to 2019, he worked as the Chief Medical Officer & Executive Vice President at Proteostasis Therapeutics, Inc. Dr. Lee holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from The Johns Hopkins University.

Former positions of Po-Shun Lee

Companies	Position	End
PROTEOSTASIS THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2019-07-21
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	2012-12-31
Critical Biologics Corp. Critical Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics drugs	Founder	-

See the detail of Po-Shun Lee's experience

Training of Po-Shun Lee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Po-Shun Lee's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Vertex Pharmaceuticals, Inc. Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis	Health Technology
Critical Biologics Corp. Critical Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics drugs	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Johns Hopkins University The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Proteostasis Therapeutics, Inc. Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases	Health Technology

See company connections